Table 1.
Characteristic | Univariate analysis | P | Multivariate analysis | P | ||
---|---|---|---|---|---|---|
RR | 95 % CI | RR | 95 % CI | |||
Sex | ||||||
Male/female | 0.586 | 0.215–1.593 | 0.288 | |||
Lesion | ||||||
Colon/rectum | 0.783 | 0.288–2.129 | 0.626 | |||
Differentiation | ||||||
tub1, tub2/muc, por | 0.302 | 0.084–1.933 | 0.173 | |||
Tumor size | ||||||
≤35 mm/>35 mm | 0.566 | 0.130–1.756 | 0.347 | |||
Depth | ||||||
T1, T2/T3, T4 | <0.0001 | 0.386–0.386 | 0.003* | <0.0001 | <0.0001–2.574 | 0.192 |
Lymph node metastasis | ||||||
Negative/positive | 0.156 | 0.036–0.483 | 0.001* | 1.852 | 0.409–6.243 | 0.383 |
Lymphatic permeation | ||||||
Negative/positive | 0.064 | 0.004–0.315 | <0.0001* | 0.103 | 0.006–0.537 | 0.004* |
Venous permeation | ||||||
Negative/positive | 0.277 | 0.064–0.861 | 0.025* | 0.890 | 0.196–2.999 | 0.860 |
Stage | ||||||
I, II/III, IV | <0.0001 | 0.0968–0.0968 | <0.0001* | <0.0001 | <0.0001–0.218 | 0.002* |
miR-132 expression | ||||||
Low/high | 7.255 | 2.026–46.207 | 0.001* | 3.838 | 1.054–24.683 | 0.040* |
RR relative risk, CI confidence interval
* Statistically significant